Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization

International Journal of Cancer

Volumn 96, Issue 4, 2001, Pages 243-252

  Cheng, Jason Chia Hsien ^a   Chuang, Vincent P ^a   Cheng, Skye Hongiun ^a   Lin, Yu Mong ^a   Cheng, Tsun I ^a   Yang, Po Sheng ^a   Jian, James Jer Min ^b   You, Dong Ling ^c   Horng, Cheng Fang ^c   Huang, Andrew T ^a  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c DUKE UNIVERSITY   (United States)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Pattern of failure; Radiotherapy

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; GELFOAM; IODINATED POPPYSEED OIL; MITOMYCIN C; POLYVINYL ALCOHOL SPONGE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; COMBINED MODALITY THERAPY; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; POLYVINYLS; RADIATION-SENSITIZING AGENTS; SEX FACTORS; TIME FACTORS;

EID: 0035921193     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1022     Document Type: Article

References (40)

1. Hepatocellular carcinoma: One of the world's most common malignancies
2. Hepatic resection in 120 patients with hepatocellular carcinoma
3. Hepatic resection for hepatocellular carcinoma
4. Primary hepatic malignancy: Surgical management and determinants of survival
5. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: Four-year follow-up
6. Transcatheter arterial chemoembolization for hepatocellular carcinoma
7. Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients
8. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma
9. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers
10. The usefulness of radiation therapy for hepatocellular carcinoma
11. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma
12. Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy
13. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy
14. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model
15. Regarding "Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma"
16. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma
17. Current treatment modalities for hepatocellular carcinoma
18. Treatment of hepatocellular carcinoma
19. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: Comparison of planned periodic chemoembolization and chemoembolization based on tumor response
20. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
21. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
22. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer
23. Chemoembolization: Transcatheter management of neoplasms
24. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
25. Hepatocellular carcinoma in the United States
26. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter
27. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases
28. Role of surgery in the treatment of primary carcinoma of the liver: A 31-year experience
29. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors
30. Primary carcinoma of the liver: A study of 282 cases in Ugandan Africans
31. Intrahepatic distant metastasis and metachronous multicentric occurrence in solitary hepatocellular carcinoma of less than five centimeters in diameter
32. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization
33. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood
34. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
35. Intrahepatic metastases in hepatocellular carcinoma: Evidence for spread via the portal vein as an efferent vessel
36. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: Analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy
37. The use of 3-D dose volume analysis to predict radiation hepatitis
38. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
39. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: A treatment design study
40. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems